docetaxel anhydrous has been researched along with chloroquine in 10 studies
| Studies (docetaxel anhydrous) | Trials (docetaxel anhydrous) | Recent Studies (post-2010) (docetaxel anhydrous) | Studies (chloroquine) | Trials (chloroquine) | Recent Studies (post-2010) (chloroquine) |
|---|---|---|---|---|---|
| 12,110 | 3,216 | 6,920 | 16,405 | 763 | 4,029 |
| Protein | Taxonomy | docetaxel anhydrous (IC50) | chloroquine (IC50) |
|---|---|---|---|
| glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase | Plasmodium berghei | 43 | |
| Spike glycoprotein | Betacoronavirus England 1 | 5.47 | |
| Replicase polyprotein 1ab | Betacoronavirus England 1 | 5.47 | |
| Transmembrane protease serine 2 | Homo sapiens (human) | 5.47 | |
| Dihydrofolate reductase | Bos taurus (cattle) | 0.0301 | |
| Amyloid-beta precursor protein | Homo sapiens (human) | 7 | |
| Histidine-rich protein PFHRP-II | Plasmodium falciparum (malaria parasite P. falciparum) | 0.2383 | |
| Procathepsin L | Homo sapiens (human) | 5.47 | |
| Replicase polyprotein 1a | Severe acute respiratory syndrome-related coronavirus | 5.47 | |
| Replicase polyprotein 1ab | Human coronavirus 229E | 5.47 | |
| Replicase polyprotein 1ab | Severe acute respiratory syndrome-related coronavirus | 5.47 | |
| Spike glycoprotein | Severe acute respiratory syndrome coronavirus 2 | 3.58 | |
| Replicase polyprotein 1ab | Severe acute respiratory syndrome coronavirus 2 | 6.375 | |
| Ribosyldihydronicotinamide dehydrogenase [quinone] | Homo sapiens (human) | 1.5 | |
| Serine/threonine-protein kinase mTOR | Homo sapiens (human) | 0.27 | |
| Beta-secretase 1 | Homo sapiens (human) | 7 | |
| Spike glycoprotein | Severe acute respiratory syndrome-related coronavirus | 5.47 | |
| Potassium voltage-gated channel subfamily H member 2 | Homo sapiens (human) | 2.503 | |
| Angiotensin-converting enzyme 2 | Homo sapiens (human) | 6.235 | |
| Cysteine proteinase falcipain 2a | Plasmodium falciparum (malaria parasite P. falciparum) | 0.02 | |
| Cysteine proteinase falcipain 2a | Plasmodium falciparum (malaria parasite P. falciparum) | 0.2 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 7 (70.00) | 24.3611 |
| 2020's | 3 (30.00) | 2.80 |
| Authors | Studies |
|---|---|
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Armstrong, JL; Birch-Machin, MA; Ellis, R; Lovat, PE; McKee, C; Wright, TJ | 1 |
| Chen, H; Feng, SS; Huang, L; Li, X; Liang, X; Mei, L; Yang, Y; Zeng, X; Zhang, X | 1 |
| Chen, H; Huang, L; Liang, X; Liu, Z; Mei, L; Tao, W; Xiao, X; Yang, Y; Zeng, X; Zhang, X | 1 |
| Luan, Y; Shi, C; Shi, J; Wang, F; Zhang, Z | 1 |
| Choi, AR; Kim, HS; Kim, JH; Woo, YH; Yoon, S | 1 |
| Hu, TT; Li, LN; Lin, JZ; Wang, WW; Wu, HF; Xu, Z; Yu, HB; Zhang, CY; Zhu, GY; Zhu, JG | 1 |
| Giatromanolaki, A; Kakouratos, C; Karakasiliotis, I; Kassela, K; Koukourakis, MI; Lamprou, I; Mitrakas, AG; Tsolou, A; Xanthopoulou, ET; Zois, CE | 1 |
| Huang, J; Lai, W; Li, G; Wang, F; Wang, J; Xie, D; Xu, R; Zhang, R; Zhou, M | 1 |
1 review(s) available for docetaxel anhydrous and chloroquine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
9 other study(ies) available for docetaxel anhydrous and chloroquine
| Article | Year |
|---|---|
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Increasing the therapeutic efficacy of docetaxel for cutaneous squamous cell carcinoma through the combined inhibition of phosphatidylinositol 3-kinase/AKT signalling and autophagy.
Topics: Analysis of Variance; Antimalarials; Antineoplastic Agents; Autophagy; Carcinoma, Squamous Cell; Chloroquine; Docetaxel; Dose-Response Relationship, Drug; Drug Therapy, Combination; Enzyme Inhibitors; Humans; Phosphoinositide-3 Kinase Inhibitors; Signal Transduction; Skin Neoplasms; Taxoids; Tumor Cells, Cultured | 2013 |
The chemotherapeutic potential of PEG-b-PLGA copolymer micelles that combine chloroquine as autophagy inhibitor and docetaxel as an anti-cancer drug.
Topics: Animals; Antineoplastic Agents; Autophagy; Cell Line, Tumor; Chloroquine; Docetaxel; Drug Delivery Systems; Female; Humans; MCF-7 Cells; Mice; Mice, SCID; Micelles; Nanomedicine; Nanoparticles; Particle Size; Polyethylene Glycols; Polyglactin 910; Taxoids | 2014 |
Enhancing therapeutic effects of docetaxel-loaded dendritic copolymer nanoparticles by co-treatment with autophagy inhibitor on breast cancer.
Topics: Animals; Antineoplastic Agents; Autophagy; Breast Neoplasms; Chloroquine; Dendrimers; Disease Models, Animal; Docetaxel; Drug Carriers; Female; Humans; Lysosomes; MCF-7 Cells; Mice, SCID; Nanoparticles; Phagosomes; Taxoids; Treatment Outcome | 2014 |
Co-delivery of docetaxel and chloroquine via PEO-PPO-PCL/TPGS micelles for overcoming multidrug resistance.
Topics: Antineoplastic Agents; Cell Death; Cell Line, Tumor; Chloroquine; Docetaxel; Drug Combinations; Drug Delivery Systems; Drug Liberation; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Synergism; Hemolysis; Humans; Micelles; Polyesters; Polyethylene Glycols; Taxoids; Vitamin E | 2015 |
Anti-malarial Drugs Primaquine and Chloroquine Have Different Sensitization Effects with Anti-mitotic Drugs in Resistant Cancer Cells.
Topics: Antimalarials; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Line, Tumor; Chloroquine; Docetaxel; Drug Resistance, Neoplasm; Humans; Mitosis; Paclitaxel; Primaquine; Taxoids; Vinblastine; Vinorelbine | 2016 |
FOXM1 contributes to docetaxel resistance in castration-resistant prostate cancer by inducing AMPK/mTOR-mediated autophagy.
Topics: AMP-Activated Protein Kinase Kinases; Apoptosis; Autophagy; Autophagy-Related Protein 7; Beclin-1; Cell Line, Tumor; Cell Proliferation; Chloroquine; Docetaxel; Drug Resistance, Neoplasm; Forkhead Box Protein M1; Gene Expression Regulation, Neoplastic; Humans; Male; Prostatic Neoplasms, Castration-Resistant; Protein Kinases; TOR Serine-Threonine Kinases | 2020 |
Suppressed PLIN3 frequently occurs in prostate cancer, promoting docetaxel resistance via intensified autophagy, an event reversed by chloroquine.
Topics: Antineoplastic Agents; Autophagy; Cell Line, Tumor; Chloroquine; Docetaxel; Drug Resistance, Neoplasm; Gene Silencing; Humans; Male; Perilipin-3; Prostatic Neoplasms | 2021 |
Autophagy responsive intra-intercellular delivery nanoparticles for effective deep solid tumor penetration.
Topics: Autophagy; Cell Line, Tumor; Chloroquine; Docetaxel; Drug Delivery Systems; Humans; Nanoparticles; Neoplasms; Tumor Microenvironment | 2022 |